Salmon farming’s balancing act. The salmon industry is once again proving that biology and economics do not always pull in the same direction. Arctic Securities has revised down its price expectations, pointing to improved survival rates and higher fish quality following the introduction of a winter ulcer vaccine. The problem? More fish are making it … Continue reading Editorial: The industry can’t afford for bad biology to be good business